Parkinson's Disease in Relation to Pesticide Exposure and Nuclear Encoded Mitochondrial Complex I Gene Variants

由 Corder, Elizabeth H., Mellick, George D.
出版 2006

The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease

由 Poortvliet, Peter Cornelis, Gluch, Alexander, Silburn, Peter A., Mellick, George D.
發表在 J Mov Disord (2021)

Perspective: Current Pitfalls in the Search for Future Treatments and Prevention of Parkinson's Disease

由 Poortvliet, Peter C., O'Maley, Karen, Silburn, Peter A., Mellick, George D.
發表在 Front Neurol (2020)

Hepatic structure-pharmacokinetic relationships: The hepatic disposition and metabolite kinetics of a homologous series of O-acyl derivatives of salicylic acid

由 Hung, Daniel Y, Mellick, George D, Anissimov, Yuri G, Weiss, Michael, Roberts, Michael S
出版 1998

Malnutrition in a Sample of Community-Dwelling People with Parkinson’s Disease

由 Sheard, Jamie M., Ash, Susan, Mellick, George D., Silburn, Peter A., Kerr, Graham K.
出版 2013

Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease

由 Sheard, Jamie M., Ash, Susan, Mellick, George D., Silburn, Peter A., Kerr, Graham K.
出版 2013

Improved nutritional status is related to improved quality of life in Parkinson’s disease

由 Sheard, Jamie M, Ash, Susan, Mellick, George D, Silburn, Peter A, Kerr, Graham K
發表在 BMC Neurol (2014)

A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan

由 Khan, Suliman, Nabi, Ghulam, Naeem, Muhammad, Ali, Liaqat, Silburn, Peter A, Mellick, George D
發表在 Neuropsychiatr Dis Treat (2016)

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease

由 Chan, Daniel Kam Yin, Xu, Ying Hua, Chan, Luke Kar Man, Braidy, Nady, Mellick, George D.
發表在 Transl Neurodegener (2017)

Singing for people with Parkinson's disease

由 Irons, J Yoon, Coren, Esther, Young, Megan K, Stewart, Donald E, Gschwandtner, Manfred, Mellick, George D
發表在 Cochrane Database Syst Rev (2019)

Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein

由 Xu, Ming-ming, Ryan, Philip, Rudrawar, Santosh, Quinn, Ronald J, Zhang, Hai-yan, Mellick, George D
發表在 Acta Pharmacol Sin (2019)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease

由 Farrer, Matthew J., Bardien, Soraya, Hattori, Nobutaka, Lesage, Suzanne, Ross, Owen A., Mellick, George D., Kruger, Rejko
發表在 Front Neurol (2021)

Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant ‘Master Regulator’ Nrf2 in Idiopathic Parkinson’s Disease

由 Todorovic, Michael, Newman, Jeremy R. B., Shan, Jianguo, Bentley, Steven, Wood, Stephen A., Silburn, Peter A., Mellick, George D.
發表在 PLoS One (2015)

Genetic Analysis of RAB39B in an Early-Onset Parkinson's Disease Cohort

由 Gao, Yujing, Wilson, Gabrielle R., Salce, Nicholas, Romano, Alexandra, Mellick, George D., Stephenson, Sarah E. M., Lockhart, Paul J.
發表在 Front Neurol (2020)

Evidence for the role of FMR1 grey zone alleles as a risk factor for parkinsonism in females

由 Loesch, Danuta Z., Tassone, Flora, Mellick, George D., Horne, Malcolm, Rubio, Justin P., Bui, Minh Q., Francis, David, Storey, Elsdon
發表在 Mov Disord (2018)

Single and dual task gait training in people with Parkinson's Disease: A protocol for a randomised controlled trial

由 Brauer, Sandra G, Woollacott, Marjorie H, Lamont, Robyn, Clewett, Sandy, O'Sullivan, John, Silburn, Peter, Mellick, George D, Morris, Meg E
出版 2011

A Cross-Study Transcriptional Analysis of Parkinson's Disease

由 Sutherland, Greg T., Matigian, Nicholas A., Chalk, Alistair M., Anderson, Matthew J., Silburn, Peter A., Mackay-Sim, Alan, Wells, Christine A., Mellick, George D.
出版 2009

Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease

由 Dissanayaka, Nadeeka N.W., White, Elizabeth, O'Sullivan, John D., Marsh, Rodney, Silburn, Peter A., Copland, David A., Mellick, George D., Byrne, Gerard J.
發表在 Mov Disord Clin Pract (2015)

Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient‐Derived Neurons

由 Hanss, Zoé, Larsen, Simone B., Antony, Paul, Mencke, Pauline, Massart, François, Jarazo, Javier, Schwamborn, Jens C., Barbuti, Peter A., Mellick, George D., Krüger, Rejko
發表在 Mov Disord (2020)

NMR Fingerprints of the Drug-like Natural-Product Space Identify Iotrochotazine A: A Chemical Probe to Study Parkinson’s Disease**

由 Grkovic, Tanja, Pouwer, Rebecca H, Vial, Marie-Laure, Gambini, Luca, Noël, Alba, Hooper, John N A, Wood, Stephen A, Mellick, George D, Quinn, Ronald J
發表在 Angew Chem Int Ed Engl (2014)